232 related articles for article (PubMed ID: 31775017)
1. Allergen-specific IgE levels and the ability of IgE-allergen complexes to cross-link determine the extent of CD23-mediated T-cell activation.
Villazala-Merino S; Rodriguez-Dominguez A; Stanek V; Campion NJ; Gattinger P; Hofer G; Froeschl R; Fae I; Lupinek C; Vrtala S; Breiteneder H; Keller W; Perkmann T; Nakamura R; Pickl WF; Valenta R; Eckl-Dorna J; Niederberger V
J Allergy Clin Immunol; 2020 Mar; 145(3):958-967.e5. PubMed ID: 31775017
[TBL] [Abstract][Full Text] [Related]
2. CD23 surface density on B cells is associated with IgE levels and determines IgE-facilitated allergen uptake, as well as activation of allergen-specific T cells.
Selb R; Eckl-Dorna J; Neunkirchner A; Schmetterer K; Marth K; Gamper J; Jahn-Schmid B; Pickl WF; Valenta R; Niederberger V
J Allergy Clin Immunol; 2017 Jan; 139(1):290-299.e4. PubMed ID: 27372566
[TBL] [Abstract][Full Text] [Related]
3. Different modes of IgE binding to CD23 revealed with major birch allergen, Bet v 1-specific monoclonal IgE.
Reginald K; Eckl-Dorna J; Zafred D; Focke-Tejkl M; Lupinek C; Niederberger V; Keller W; Valenta R
Immunol Cell Biol; 2013 Feb; 91(2):167-72. PubMed ID: 23229638
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of CD23-dependent facilitated allergen binding to B cells following vaccination with genetically modified hypoallergenic Bet v 1 molecules.
Pree I; Shamji MH; Kimber I; Valenta R; Durham SR; Niederberger V
Clin Exp Allergy; 2010 Sep; 40(9):1346-52. PubMed ID: 20604801
[TBL] [Abstract][Full Text] [Related]
5. A nonallergenic birch pollen allergy vaccine consisting of hepatitis PreS-fused Bet v 1 peptides focuses blocking IgG toward IgE epitopes and shifts immune responses to a tolerogenic and Th1 phenotype.
Marth K; Breyer I; Focke-Tejkl M; Blatt K; Shamji MH; Layhadi J; Gieras A; Swoboda I; Zafred D; Keller W; Valent P; Durham SR; Valenta R
J Immunol; 2013 Apr; 190(7):3068-78. PubMed ID: 23440415
[TBL] [Abstract][Full Text] [Related]
6. A double-blind, placebo-controlled birch allergy vaccination study: inhibition of CD23-mediated serum-immunoglobulin E-facilitated allergen presentation.
van Neerven RJ; Arvidsson M; Ipsen H; Sparholt SH; Rak S; Würtzen PA
Clin Exp Allergy; 2004 Mar; 34(3):420-8. PubMed ID: 15005736
[TBL] [Abstract][Full Text] [Related]
7. Blocking antibodies induced by specific allergy vaccination prevent the activation of CD4+ T cells by inhibiting serum-IgE-facilitated allergen presentation.
van Neerven RJ; Wikborg T; Lund G; Jacobsen B; Brinch-Nielsen A; Arnved J; Ipsen H
J Immunol; 1999 Sep; 163(5):2944-52. PubMed ID: 10453043
[TBL] [Abstract][Full Text] [Related]
8. An in vitro model for the allergen-IgE-FcARI interaction.
Laffer S; Hogbom E; Adrianson J; Grönlund H; Sillaber C; Valent P; Vangelista L; Kricek F; Kraft D; Valenta R
Int Arch Allergy Immunol; 1999; 118(2-4):116-8. PubMed ID: 10224355
[TBL] [Abstract][Full Text] [Related]
9. A double-blind placebo-controlled birch allergy vaccination study II: correlation between inhibition of IgE binding, histamine release and facilitated allergen presentation.
Würtzen PA; Lund G; Lund K; Arvidsson M; Rak S; Ipsen H
Clin Exp Allergy; 2008 Aug; 38(8):1290-301. PubMed ID: 18510696
[TBL] [Abstract][Full Text] [Related]
10. Human blood basophils do not act as antigen-presenting cells for the major birch pollen allergen Bet v 1.
Kitzmüller C; Nagl B; Deifl S; Walterskirchen C; Jahn-Schmid B; Zlabinger GJ; Bohle B
Allergy; 2012 May; 67(5):593-600. PubMed ID: 22188598
[TBL] [Abstract][Full Text] [Related]
11. Oral exposure to Mal d 1 affects the immune response in patients with birch pollen allergy.
Geroldinger-Simic M; Kinaciyan T; Nagl B; Baumgartner-Durchschlag U; Huber H; Ebner C; Lidholm J; Bartel D; Vieths S; Jahn-Schmid B; Bohle B
J Allergy Clin Immunol; 2013 Jan; 131(1):94-102. PubMed ID: 22921871
[TBL] [Abstract][Full Text] [Related]
12. Critical and direct involvement of the CD23 stalk region in IgE binding.
Selb R; Eckl-Dorna J; Twaroch TE; Lupinek C; Teufelberger A; Hofer G; Focke-Tejkl M; Gepp B; Linhart B; Breiteneder H; Ellinger A; Keller W; Roux KH; Valenta R; Niederberger V
J Allergy Clin Immunol; 2017 Jan; 139(1):281-289.e5. PubMed ID: 27343203
[TBL] [Abstract][Full Text] [Related]
13. The major birch pollen allergen Bet v 1 induces different responses in dendritic cells of birch pollen allergic and healthy individuals.
Smole U; Radauer C; Lengger N; Svoboda M; Rigby N; Bublin M; Gaier S; Hoffmann-Sommergruber K; Jensen-Jarolim E; Mechtcheriakova D; Breiteneder H
PLoS One; 2015; 10(1):e0117904. PubMed ID: 25635684
[TBL] [Abstract][Full Text] [Related]
14. Vig r 6, the cytokinin-specific binding protein from mung bean (Vigna radiata) sprouts, cross-reacts with Bet v 1-related allergens and binds IgE from birch pollen allergic patients' sera.
Guhsl EE; Hofstetter G; Hemmer W; Ebner C; Vieths S; Vogel L; Breiteneder H; Radauer C
Mol Nutr Food Res; 2014 Mar; 58(3):625-34. PubMed ID: 23996905
[TBL] [Abstract][Full Text] [Related]
15. Birch pollen immunotherapy results in long-term loss of Bet v 1-specific TH2 responses, transient TR1 activation, and synthesis of IgE-blocking antibodies.
Möbs C; Ipsen H; Mayer L; Slotosch C; Petersen A; Würtzen PA; Hertl M; Pfützner W
J Allergy Clin Immunol; 2012 Nov; 130(5):1108-1116.e6. PubMed ID: 23021882
[TBL] [Abstract][Full Text] [Related]
16. Kinetics, cross-reactivity, and specificity of Bet v 1-specific IgG4 antibodies induced by immunotherapy with birch pollen.
Subbarayal B; Schiller D; Möbs C; de Jong NW; Ebner C; Reider N; Bartel D; Lidholm J; Pfützner W; Gerth van Wijk R; Vieths S; Bohle B
Allergy; 2013 Nov; 68(11):1377-86. PubMed ID: 24053565
[TBL] [Abstract][Full Text] [Related]
17. Mapping of conformational IgE epitopes with peptide-specific monoclonal antibodies reveals simultaneous binding of different IgE antibodies to a surface patch on the major birch pollen allergen, Bet v 1.
Gieras A; Cejka P; Blatt K; Focke-Tejkl M; Linhart B; Flicker S; Stoecklinger A; Marth K; Drescher A; Thalhamer J; Valent P; Majdic O; Valenta R
J Immunol; 2011 May; 186(9):5333-44. PubMed ID: 21451110
[TBL] [Abstract][Full Text] [Related]
18. A novel role for neutrophils in IgE-mediated allergy: Evidence for antigen presentation in late-phase reactions.
Polak D; Hafner C; Briza P; Kitzmüller C; Elbe-Bürger A; Samadi N; Gschwandtner M; Pfützner W; Zlabinger GJ; Jahn-Schmid B; Bohle B
J Allergy Clin Immunol; 2019 Mar; 143(3):1143-1152.e4. PubMed ID: 29920351
[TBL] [Abstract][Full Text] [Related]
19. Formation of IgE-Allergen-CD23 Complex Changes in Children Treated with Subcutaneous Immunotherapy for Japanese Cedar Pollinosis.
Asaumi T; Sato S; Yanagida N; Matsuhara H; Kobayashi S; Fukano C; Ohashi-Doi K; Ebisawa M
Int Arch Allergy Immunol; 2021; 182(3):190-194. PubMed ID: 33032294
[TBL] [Abstract][Full Text] [Related]
20. Intranasal administration of allergen increases specific IgE whereas intranasal omalizumab does not increase serum IgE levels-A pilot study.
Eckl-Dorna J; Fröschl R; Lupinek C; Kiss R; Gattinger P; Marth K; Campana R; Mittermann I; Blatt K; Valent P; Selb R; Mayer A; Gangl K; Steiner I; Gamper J; Perkmann T; Zieglmayer P; Gevaert P; Valenta R; Niederberger V
Allergy; 2018 May; 73(5):1003-1012. PubMed ID: 29083477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
